One health
Communicable diseases remain one of the major causes of mortality worldwide. There are disparities in the numbers of individuals affected by disease between low-and-middle-income countries and those in developed nations. Microbes will play in important role in drug discovery: producing anticancer drugs and antimicrobials. Applying One Health principles, to understand the interaction of pathogens and the human host, development of diagnostics, treatments, and disease prevention, applied microbiologists can shape global health and wellbeing outcomes.
News
Researchers uncover unexpected twist in fight against antibiotic resistance
A group of Cornell College students and their professor have discovered surprising results in their research on antimicrobial peptides, which are being studied as a method of combating antibiotic resistance.
Read story
NewsMeningococcal B vaccine linked to lower gonorrhoea risk
The meningococcal B vaccine could provide protection against more than one disease, with new research linking it to a significant reduction in the risk of gonorrhoea in young people in Australia.
NewsResearchers develop new drug to attack an enduring killer
Researchers have developed a new antimalarial drug designed to thwart even the most drug-resistant forms of the infection.
NewsLong non-coding RNAs offer new hope for earlier detection and improved treatment of liver cancer linked to hepatitis B
Long non-coding RNAs may play a pivotal role in shaping the future of diagnosis, prognosis, and treatment in HBV-associated liver disease.
More One Health
News
How ‘good’ bacteria from fecal transplants reduce peanut allergy
Researchers found that some participants with peanut allergies experienced a higher tolerance to peanuts months after receiving a fecal transplant from a healthy donor without food allergies.
NewsSevere COVID-19 reactivates dormant viruses, study finds
Better understanding of how these activated viruses contribute to COVID-related outcomes could help physicians better predict potential complications and improve treatment for patients with severe COVID infection.
NewsHidden microbial ecosystems inside tumors reveal new frontiers for cancer treatment
Far from being sterile, tumors host complex communities of bacteria, fungi, and viruses that actively influence disease progression, immune responses, and treatment outcomes. A review highlights how these microbial populations function as key regulators of tumor immunity.
NewsA lesser-known SARS-CoV-2 protein may offer clues to long COVID symptoms
A new study describes a previously unrecognized way the SARS-CoV-2 nucleocapsid protein can push the immune system into dangerous overdrive.
NewsWidely used early warning score may help guide the urgency of antibiotic treatment for suspected sepsis
Large cohort study suggests the National Early Warning Score (NEWS2) may provide a more comprehensive framework than current guidance for determining which patients with suspected sepsis benefit from immediate antibiotics.
NewsNew vaccine strategy protects against chikungunya and could become a platform for combating other diseases
Researchers created a genetically modified version of the Chikungunya virus that replicates only once, yet still trains the immune system to defend itself without causing disease.
NewsNight shift work linked to a higher risk of long COVID
People working night shifts were nearly twice as likely to develop long COVID, while chronic insomnia further increased the risk, according to a study based on the COVICAT cohort.
NewsAdults living with HIV are at high risk for diabetes. Here’s why.
A new study helps explain why people with HIV remain at elevated risk for type 2 diabetes despite effective suppression of the virus with modern medications.
NewsU.S. disease tracker launches to strengthen monitoring of vaccine-preventable diseases
A new website will track the spread of vaccine-preventable diseases across the United States to offer the public, the media, healthcare providers, public health officials, and policymakers reliable and visual information about current disease trends.
NewsMXene-based hydrogel disrupts bacterial biofilms and reprograms immune cell metabolism to reverse bone resorption in periodontitis
Periodontitis treatment not only requires effectively disrupting bacterial biofilms but also reshaping the local immune metabolic microenvironment to fundamentally break the vicious cycle of “infection-inflammation-bone resorption.”
NewsHow do vaccine conspiracy beliefs develop?
Researchers analyzed five years of longitudinal panel survey data collected between 2020 and 2024 and examined how vaccine-related conspiracy beliefs were associated with media skepticism during the COVID-19 pandemic.
NewsDoes eczema increase the risk of developing shingles?
New research indicates that people with eczema face an elevated risk of developing shingles.
NewsLemurs fall prey to human herpes virus
A new study marks the first time researchers have been able to confirm human herpesvirus in lemurs via a molecular analysis, outlining the cases of four privately owned animals who died from the illness.
NewsBiofortified millet benefits toddlers without supplement side effects
Toddlers who ate iron- and zinc-biofortified pearl millet for nine months did not experience adverse effects typically associated with increased iron intake and developed gut microbiomes with distinct and potentially beneficial changes.
NewsFirst immune pathway discovered that stops a normally harmless fungus spreading through the body and causing deadly disease
An immune pathway has been discovered which prevents a normally harmless fungus developing into a fatal infection.
NewsMalaria causes permanent damage to phagocytes in the spleen
A new study has shown that recruited macrophages are only capable of replacing resident ones to a limited extent during malarial infection.
NewsPromising single-dose malaria treatment advances toward pan-African clinical trial
A promising single-dose malaria treatment that could help address growing drug resistance and simplify treatment for patients.
NewsDo human noroviruses also switch their shape?
Researchers investigating whether human norovirus undergoes conformational changes in response to environmental condition successfully produced virus-like particles (VLPs) of the human norovirus GII.3 strain and determined their structures.
NewsIntratumoral Fusobacterium as a prognostic and predictive biomarker in resectable colorectal cancer
Research supports the use of Fusobacterium as a prognostic and predictive biomarker in patients with resectable stage I–III CRC. Its presence was associated with more aggressive disease, a weaker immune response, and limited benefit from adjuvant chemotherapy.